Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)

RAJAF Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	0.82	-0.72	-0.49	-0.02
Depreciation & Amortization	0.14	0.08	0	0.04
Other Operating Activities	-0.62	0.3	0.37	-
Change in Accounts Receivable	-0.01	-	-0.01	-0
Change in Inventory	-0.19	-0	-	-1
Change in Accounts Payable	0.11	-	-	0.75
Change in Other Net Operating Assets	-0.05	-0.06	-0.02	0.04
Operating Cash Flow	0.32	-0.32	-0.37	-0.2
Capital Expenditures	-0.21	-	-0.1	-1.67
Other Investing Activities	0.09	-0	-0.01	-0.58
Investing Cash Flow	-0.12	-0	-0.11	-2.25
Short-Term Debt Issued	0.01	0.31	0.18	-
Total Debt Issued	0.01	0.31	0.18	2.47
Short-Term Debt Repaid	-	-	-0.08	-
Total Debt Repaid	-	-	-0.08	-0.03
Net Debt Issued (Repaid)	0.01	0.31	0.1	2.45
Issuance of Common Stock	-	-	0.23	-
Other Financing Activities	-0.27	-0.06	0.25	-
Financing Cash Flow	-0.26	0.25	0.57	2.45
Foreign Exchange Rate Adjustments	0.06	-0.01	0	0
Net Cash Flow	-0	-0.08	0.1	0
Free Cash Flow	0.12	-0.32	-0.47	-1.86
Free Cash Flow Margin	13.29%	-602.91%	-	-922.13%
Free Cash Flow Per Share	0.00	-0.00	-0.01	-0.02
Cash Income Tax Paid	-	-	-	0
Levered Free Cash Flow	0.58	1.53	-0.08	-
Unlevered Free Cash Flow	0.6	1.53	-0.08	-
Change in Net Working Capital	-0.52	-1.7	-0.09	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.